Last reviewed · How we verify

Intracervical injection of Vasopressin

Prisma Health-Upstate · FDA-approved active Small molecule

Intracervical injection of Vasopressin is a Vasopressor agent Small molecule drug developed by Prisma Health-Upstate. It is currently FDA-approved for Hemostasis during cervical procedures (e.g., cervical conization, myomectomy, dilation and curettage).

Vasopressin acts as a vasoconstrictor that reduces bleeding by constricting blood vessels in the cervix when injected directly into cervical tissue.

Vasopressin acts as a vasoconstrictor that reduces bleeding by constricting blood vessels in the cervix when injected directly into cervical tissue. Used for Hemostasis during cervical procedures (e.g., cervical conization, myomectomy, dilation and curettage).

At a glance

Generic nameIntracervical injection of Vasopressin
SponsorPrisma Health-Upstate
Drug classVasopressor agent
TargetV1 vasopressin receptor
ModalitySmall molecule
Therapeutic areaGynecology
PhaseFDA-approved

Mechanism of action

Vasopressin is a potent vasopressor agent that binds to V1 receptors on vascular smooth muscle, causing vasoconstriction. When injected intracervically, it reduces blood flow to the injection site and surrounding cervical tissue, thereby decreasing hemorrhage. This local hemostatic effect is utilized during gynecological procedures to minimize blood loss.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Intracervical injection of Vasopressin

What is Intracervical injection of Vasopressin?

Intracervical injection of Vasopressin is a Vasopressor agent drug developed by Prisma Health-Upstate, indicated for Hemostasis during cervical procedures (e.g., cervical conization, myomectomy, dilation and curettage).

How does Intracervical injection of Vasopressin work?

Vasopressin acts as a vasoconstrictor that reduces bleeding by constricting blood vessels in the cervix when injected directly into cervical tissue.

What is Intracervical injection of Vasopressin used for?

Intracervical injection of Vasopressin is indicated for Hemostasis during cervical procedures (e.g., cervical conization, myomectomy, dilation and curettage).

Who makes Intracervical injection of Vasopressin?

Intracervical injection of Vasopressin is developed and marketed by Prisma Health-Upstate (see full Prisma Health-Upstate pipeline at /company/prisma-health-upstate).

What drug class is Intracervical injection of Vasopressin in?

Intracervical injection of Vasopressin belongs to the Vasopressor agent class. See all Vasopressor agent drugs at /class/vasopressor-agent.

What development phase is Intracervical injection of Vasopressin in?

Intracervical injection of Vasopressin is FDA-approved (marketed).

What are the side effects of Intracervical injection of Vasopressin?

Common side effects of Intracervical injection of Vasopressin include Hypertension, Tachycardia, Pallor, Tremor.

What does Intracervical injection of Vasopressin target?

Intracervical injection of Vasopressin targets V1 vasopressin receptor and is a Vasopressor agent.

Related